These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 17213593)
1. [Myeloperoxidase in the plasma of patients with acute coronary syndrome]. Ouyang M; Yang K; Zhang MX; Jiang WH; Cao Y; Wang JG; Gao YD Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):901-5. PubMed ID: 17213593 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients. Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain. Granér M; Tikkanen E; Rimpilä O; Tikkanen H; Ripatti S; Lokki ML; Nieminen MS; Taskinen MR; Sinisalo J Ann Med; 2013 Jun; 45(4):322-7. PubMed ID: 23651064 [TBL] [Abstract][Full Text] [Related]
4. [Changes of neutrophil myeloperoxidase in coronary circulation among patients with acute coronary syndrome]. Li L; Zhang Y; Chen YG; Li GS; Wang Y; Ma X; Li JF; Zhong M; Zhang W Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1106-8. PubMed ID: 16563281 [TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes. Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Schömig A; Kastrati A Eur J Clin Invest; 2008 Feb; 38(2):90-6. PubMed ID: 18226042 [TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of myeloperoxidase concentration in patients with acute coronary syndrome]. Liu SC; Yi TC; Weng HY; Zhang L; Li YX; Mohetaboer M; Zhang Y; Jiang J; Li JP; Huo Y Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Apr; 46(4):284-291. PubMed ID: 29747324 [No Abstract] [Full Text] [Related]
7. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. Cavusoglu E; Ruwende C; Eng C; Chopra V; Yanamadala S; Clark LT; Pinsky DJ; Marmur JD Am J Cardiol; 2007 May; 99(10):1364-8. PubMed ID: 17493461 [TBL] [Abstract][Full Text] [Related]
8. Association between serum resistin level and cardiovascular events in postmenopausal women with acute coronary syndrome undergoing percutaneous coronary intervention. Li L; Han JL; Mao JM; Guo LJ; Gao W Chin Med J (Engl); 2013 Mar; 126(6):1058-62. PubMed ID: 23506578 [TBL] [Abstract][Full Text] [Related]
10. [Clinical implications of relationship between myeloperoxidase and acute coronary syndromes]. Li SH; Xing YW; Li ZZ; Bai SG; Wang J Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Mar; 35(3):241-4. PubMed ID: 17582289 [TBL] [Abstract][Full Text] [Related]
11. Elevated serum myeloperoxidase activities are significantly associated with the prevalence of ACS and High LDL-C levels in CHD patients. Liu C; Xie G; Huang W; Yang Y; Li P; Tu Z J Atheroscler Thromb; 2012; 19(5):435-43. PubMed ID: 22659527 [TBL] [Abstract][Full Text] [Related]
12. Association between HDL particles size and myeloperoxidase/ paraoxonase-1 (MPO/PON1) ratio in patients with acute coronary syndrome. Emami Razavi A; Basati G; Varshosaz J; Abdi S Acta Med Iran; 2013 Jul; 51(6):365-71. PubMed ID: 23852840 [TBL] [Abstract][Full Text] [Related]
13. Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction. Aminian A; Boudjeltia KZ; Babar S; Van Antwerpen P; Lefebvre P; Crasset V; Leone A; Ducobu J; Friart A; Vanhaeverbeek M Eur J Intern Med; 2009 Sep; 20(5):527-32. PubMed ID: 19712859 [TBL] [Abstract][Full Text] [Related]
14. [Value of biochemical marker detection in risk stratification in patients with acute coronary syndrome]. Liu B; Fu Q; Yan QN; Jin W; Tao DP; Hua JH; Li ZL Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1015-9. PubMed ID: 20501382 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease. Stefanescu A; Braun S; Ndrepepa G; Koppara T; Pavaci H; Mehilli J; Schömig A; Kastrati A Am Heart J; 2008 Feb; 155(2):356-60. PubMed ID: 18215608 [TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum. Peacock WF; Nagurney J; Birkhahn R; Singer A; Shapiro N; Hollander J; Glynn T; Nowak R; Safdar B; Miller C; Peberdy M; Counselman F; Chandra A; Kosowsky J; Neuenschwander J; Schrock J; Plantholt S; Lewandrowski E; Wong V; Kupfer K; Diercks D Am Heart J; 2011 Nov; 162(5):893-9. PubMed ID: 22093206 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes. Sawicki M; Sypniewska G; Kozinski M; Gruszka M; Krintus M; Obonska K; Pilaczynska-Cemel M; Kubica J Eur J Clin Invest; 2011 Jun; 41(6):667-71. PubMed ID: 21226709 [TBL] [Abstract][Full Text] [Related]
19. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of MPO in patients admitted for suspected acute coronary syndrome--a study of adult in Mostar, Bosnia and Herzegovina. Vasilj M; Starcević B; Volarić M; Jelavić B; Leventić M; Cuk D; Corić S Coll Antropol; 2014 Mar; 38(1):213-7. PubMed ID: 24851620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]